AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Ostlund, E Hansson, LO Bremme, K
Citation: E. Ostlund et al., Fibronectin is a marker for organ involvement and may reflect the severityof preeclampsia, HYPERTENS P, 20(1), 2001, pp. 79-87

Authors: Bremme, K van Rooijen, M Yu, A Blomback, M
Citation: K. Bremme et al., Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy, BL COAG FIB, 12(2), 2001, pp. 149-155

Authors: Wramsby, ML Bremme, K Blomback, M
Citation: Ml. Wramsby et al., Measurement of activated protein C resistance during menstrual cycle in women with and without the Leiden mutation, THROMB HAEM, 85(4), 2001, pp. 614-618

Authors: Ekstrom, ES Bengtsson, A Svensson, A Nilsson, C Ostlund, E Sandstedt, B Bremme, K Lilja, G Scheynius, A
Citation: Es. Ekstrom et al., Presence of CD30(+) and CD30L(+) cells in human placenta and soluble CD30 levels in cord blood are independent of maternal atopy, PLACENTA, 22(4), 2001, pp. 372-379

Authors: van Rooijen, M Bremme, K
Citation: M. Van Rooijen et K. Bremme, A family history can display a synergistic effect of atherogenic and prothrombotic risk in pregnancy, ACT OBST SC, 80(9), 2001, pp. 873-874

Authors: Larson, B Bremme, K Clyne, N Nordstrom, L
Citation: B. Larson et al., Preoperative treatment of anemic women with epoetin beta, ACT OBST SC, 80(6), 2001, pp. 559-562

Authors: Olofsson, C Bremme, K Forssell, G Ohqvist, G
Citation: C. Olofsson et al., Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension, ACT ANAE SC, 45(2), 2001, pp. 258-260

Authors: He, S Wramsby, M Bokarewa, M Blomback, M Bremme, K
Citation: S. He et al., Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy, J THROMB TH, 9(3), 2000, pp. 277-281

Authors: Wramsby, ML Sten-Linder, M Bremme, K
Citation: Ml. Wramsby et al., Primary habitual abortions are associated with high frequency of Factor V Leiden mutation, FERT STERIL, 74(5), 2000, pp. 987-991

Authors: Osman, K Akesson, A Berglund, M Bremme, K Schutz, A Ask, K Vahter, M
Citation: K. Osman et al., Toxic and essential elements in placentas of Swedish women, CLIN BIOCH, 33(2), 2000, pp. 131-138

Authors: He, S Bremme, K Blomback, M
Citation: S. He et al., Can the laboratory assay of protein C activity assist in monitoring the hemostatic function in pre-eclampsia?, BL COAG FIB, 10(3), 1999, pp. 127-132

Authors: He, S Silveira, A Hamsten, A Blomback, M Bremme, K
Citation: S. He et al., Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia, THROMB HAEM, 81(4), 1999, pp. 538-542

Authors: He, S Bremme, K Blomback, M
Citation: S. He et al., A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results, THROMB RES, 96(2), 1999, pp. 145-156

Authors: Shanwell, A Sallander, S Bremme, K Westgren, M
Citation: A. Shanwell et al., Clinical evaluation of a solid-phase test for red cell antibody screening of pregnant women, TRANSFUSION, 39(1), 1999, pp. 26-31

Authors: Akesson, A Bjellerup, P Berglund, M Bremme, K Vahter, M
Citation: A. Akesson et al., Serum transferrin receptor: a specific marker of iron deficiency in pregnancy (vol 68, pg 1241, 1998), AM J CLIN N, 69(4), 1999, pp. 743-743

Authors: Bokarewa, MI Wramsby, M Bremme, K
Citation: Mi. Bokarewa et al., Reactivity against phospholipids during pregnancy, HUM REPR, 13(9), 1998, pp. 2633-2635

Authors: Akesson, A Bjellerup, P Berglund, M Bremme, K Vahter, M
Citation: A. Akesson et al., Serum transferrin receptor: a specific marker of iron deficiency in pregnancy, AM J CLIN N, 68(6), 1998, pp. 1241-1246
Risultati: 1-17 |